ClinicalTrials.govpublic full text
STUDY TO DETERMINE THE EFFICACY AND SAFETY OF STANDARD SCHEDULE VERSUS A NEW ALGORITHM OF DOSE REDUCTIONS IN ELDERLY AND UNFIT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE PLUS STEROIDS
multiple myeloma, diagnosis, elderly and unfit patients, lenalidomide plus steroids, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 902187
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.